RUNX3 gene expression confers an independent Overall survival advantage in non-M3 adult acute myeloid leukemia patients in Egypt.
Mourtada, F., Assem, M., El Leithy, A., Hassan, N., Hassan, N. (2020). RUNX3 gene expression confers an independent Overall survival advantage in non-M3 adult acute myeloid leukemia patients in Egypt.. EKB Journal Management System, 4(2), 87-98. doi: 10.21608/jcbr.2020.27668.1027
Fatima Abbas Mourtada; Magda Mahmoud Assem; Asmaa El Leithy; Naglaa Moustafa Hassan; Nagwa Hassan Ali Hassan. "RUNX3 gene expression confers an independent Overall survival advantage in non-M3 adult acute myeloid leukemia patients in Egypt.". EKB Journal Management System, 4, 2, 2020, 87-98. doi: 10.21608/jcbr.2020.27668.1027
Mourtada, F., Assem, M., El Leithy, A., Hassan, N., Hassan, N. (2020). 'RUNX3 gene expression confers an independent Overall survival advantage in non-M3 adult acute myeloid leukemia patients in Egypt.', EKB Journal Management System, 4(2), pp. 87-98. doi: 10.21608/jcbr.2020.27668.1027
Mourtada, F., Assem, M., El Leithy, A., Hassan, N., Hassan, N. RUNX3 gene expression confers an independent Overall survival advantage in non-M3 adult acute myeloid leukemia patients in Egypt.. EKB Journal Management System, 2020; 4(2): 87-98. doi: 10.21608/jcbr.2020.27668.1027

RUNX3 gene expression confers an independent Overall survival advantage in non-M3 adult acute myeloid leukemia patients in Egypt.

Egyptian Journal of Cancer and Biomedical Research
Article 3, Volume 4, Issue 2, August 2020, Page 87-98  XML PDF (1.13 MB)
Document Type: Original Article
DOI: 10.21608/jcbr.2020.27668.1027
View on SCiNiTO View on SCiNiTO
Authors
Fatima Abbas Mourtada email 1; Magda Mahmoud Assem2; Asmaa El Leithy3; Naglaa Moustafa Hassan4; Nagwa Hassan Ali Hassan5
1Zoology Department, Faculty of Science, Ain Shams University, Cairo, Egypt
2Clinical Pathology Department, National Cancer Institute, Cairo University ,Cairo, Egypt
3Cellular and Molecular Biology Department, Collage of Biotechnology, Misr University for Science and Technolgy, Cairo, Egypt
4Clinical Pathology Department, National Cancer Institute, Cairo University,Cairo, Egypt
5Cytogenetics, Zoology Department, Faculty of Science, Ain Shams University, Cairo, Egypt
Abstract
Pretreatment bone marrow samples from 46 newly diagnosed acute myeloid leukemia (AML) patients were analyzed by qRT-PCR. The aim of the present study was to evaluate mRNA expression of RUNX1,2 and 3 along with the hedgehog ligands Indian hedgehog(IHH) and Sonic hedgehog (SHH) and correlated their expressions with various clinicopathological parameters in adult human Egyptian (AML) patients. AML patients had significantly increased expression of RUNX1 & RUNX2 and significantly decreased expression of the Hedgehog ligands (IHH&SHH) compared to normal bone marrow samples.
Spearman Correlation Coefficient test showed positive correlation of RUNX3 gene expression with platelet count, but a significant negative correlation with total leukocytic count and peripheral blood blasts. This reduced circulating tumor burden induced by RUNX3 overexpression, was not significantly reflected upon complete remission induction. But was clearly manifested by a significantly improved overall survival (P=0.015) on univariate analysis. Multivariate analysis showed that higher expression of RUNX3 & increased hemoglobin level were the only independent factors which affect OS significantly. This significant effect was not achieved by any of the other four studied genes.
Ectopic co-expression of the hedgehog ligands: Indian hedgehog (IHH) & Sonic hedgehog (SHH) in AML was observed. No significant correlation between RUNX3expression & either IHH or SHH was observed. The link between HH pathway & RUNXs family members was provided by a significant positive correlation between RUNX2& IHH. In conclusion, RUNX3 over expression is a good prognostic factor in Egyptian adult non-M3 AML.
Keywords
RUNX3; acute myeloid leukemia; M3; RUNX2; RUNX1
Statistics
Article View: 370
PDF Download: 358